Skip to content
Drug recall · FDA · Published November 19, 2019

AuroMedics Pharma LLC recalls Gabapentin Capsules, USP 100 mg, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65682-198-99

AuroMedics Pharma LLC recalls Gabapentin 100mg capsules (NDC 65682-198-99) due to foreign Losartan/HCTZ tablets found in some bottles. This may cause confusion with other medications.

🇺🇸 FDA recall #D-0653-2020DrugAuroMedics ›
Take action

Contact the company & request your remedy

Recalling firmAuroMedics Pharma LLC279 Princeton Hightstown Rd · East Windsor, NJ 08520-1401
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

AuroMedics Pharma LLC is recalling Gabapentin 100mg capsules (NDC 65682-198-99) because some bottles contain foreign Losartan/HCTZ tablets. This could lead to medication confusion if someone takes the wrong pills. Read more at govinfonow.com/recall/37689-auromedics-gabapentin-capsules-recall-foreign-losartan-hctz-tablets-found.

Source Summary by GovInfoNow · govinfonow.com/recall/37689-auromedics-gabapentin-capsules-recall-foreign-losartan-hctz-tablets-found · Updated October 5, 2026 · FDA enforcement record: FDA #D-0653-2020

Cite this page

“AuroMedics Gabapentin Capsules Recall: Foreign Losartan/HCTZ Tablets Found.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37689-auromedics-gabapentin-capsules-recall-foreign-losartan-hctz-tablets-found. Based on FDA recall #D-0653-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0653-2020%22&limit=1).

Why it’s dangerous

The recall involves foreign Losartan/HCTZ tablets being present in some Gabapentin 1000-count bottles. This could cause confusion if someone mistakenly takes the foreign tablets instead of the intended Gabapentin capsules.

Who’s affected

Prescription patients who received the recalled Gabapentin capsules from Aurobindo Pharma USA, Inc. in Dayton, NJ. Those most at risk are individuals taking the capsules for conditions like neuropathy or seizures.

How to tell if you have this one

Check for the NDC code 65682-198-99 on the bottle label. The recall applies to Gabapentin capsules (100mg, Rx only) distributed by Aurobindo Pharma USA, Inc. in Dayton, NJ.

  • Brand
    AuroMedics
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Capsules

    Look for the NDC code 65682-198-99 on the bottle label to confirm if you have the recalled product.

✎ GovInfoNow

Questions people ask

Why was this product recalled?

The recall was initiated because foreign Losartan/HCTZ tablets were found in some Gabapentin 1000-count bottles.

What should I do if I have the recalled product?

Check the NDC code 65682-198-99 on the bottle label. If you have the recalled product, contact Aurobindo Pharma USA, Inc. for guidance.

Is there a risk of serious injury from this recall?

The recall involves foreign tablets found in the product, which could cause medication confusion but does not pose a direct risk of serious injury.

Take action

Contact AuroMedics

We’ve drafted a message you can send AuroMedics to request your refund or repair — edit it as you like.

Subject: Recall D-0653-2020 — AuroMedics AuroMedics

Hello,

I own a AuroMedics that is covered by recall D-0653-2020 from AuroMedics.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0653-2020 (November 19, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0653-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA